Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

301
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
301
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.4K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

696
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
696
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

225
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
225
Ideal Solutions02:24

Ideal Solutions

22.5K
According to Raoult’s law, the partial vapor pressure of a solvent in a solution is equal or identical to the vapor pressure of the pure solvent multiplied by its mole fraction in the solution. However, Raoult's Law is only valid for ideal solutions. For a solution to be ideal, the solvent-solute interaction must be just as strong as a solvent-solvent or solute-solute interaction. This suggests that both the solute and the solvent would use the same amount of energy to escape to the...
22.5K
General Properties of Solutions02:12

General Properties of Solutions

36.0K
Many common substances around us exist as a solution, such as ocean water, air, and gasoline. All solutions are mixtures of substances that are composed of varying amounts of two or more types of atoms or molecules. A mixture with a non-uniform composition is a heterogeneous mixture, whereas a mixture with a uniform composition is a homogeneous mixture. The components that make the homogeneous mixture are evenly spread out and thoroughly mixed. 
36.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Potentially Inappropriate Medications for Adults Below 65 Years: Protocol for a Modified Delphi Study.

JMIR research protocols·2026
Same author

Development and evaluation of an e-learning program on drug-related problems for community pharmacists.

International journal of clinical pharmacy·2026
Same author

[Concepts to improve medication safety in older patients].

Innere Medizin (Heidelberg, Germany)·2026
Same author

General practitioner-pharmacist collaboration to enhance deprescribing of psychotropics, sedatives, and anticholinergics among older polypharmacy patients in primary care: study protocol of a cluster-randomized controlled trial (PARTNER).

Therapeutic advances in drug safety·2026
Same author

A Multicentre Evaluation of the Impact of Computerised Physician Order Entry on Medication Documentation Workflow, Time, and Quality.

Methods of information in medicine·2025
Same author

A Novel Screening Method to Prioritise Cardiovascular Patients Receiving a Pharmaceutical Care Intervention and the Effects on Patients' Difficulties with Managing Their Drug Treatment.

Patient preference and adherence·2025

Related Experiment Video

Updated: Feb 7, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.8K

[Simplifying complex drug therapies : Challenges and solutions].

Viktoria S Wurmbach1,2, Anette Lampert1,2, Steffen J Schmidt3

  • 1Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|August 2, 2018
PubMed
Summary
This summary is machine-generated.

Managing complex medication regimens, or polypharmacy, is challenging for patients. Electronic decision support systems can help simplify drug therapy, potentially improving patient adherence and reducing adverse events.

Keywords:
Analysis of medication complexityDrug administrationMedication adherenceMedication schedulePatient preferencePolypharmacy

More Related Videos

Setting Limits on Supersymmetry Using Simplified Models
07:46

Setting Limits on Supersymmetry Using Simplified Models

Published on: November 15, 2013

9.0K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.6K

Related Experiment Videos

Last Updated: Feb 7, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.8K
Setting Limits on Supersymmetry Using Simplified Models
07:46

Setting Limits on Supersymmetry Using Simplified Models

Published on: November 15, 2013

9.0K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.6K

Area of Science:

  • Pharmacology
  • Health Informatics
  • Patient Care

Background:

  • Managing complex medication regimens (polypharmacy) is often underestimated in outpatient settings.
  • High drug counts and complicated dosing schedules can overwhelm patients, leading to treatment errors and adverse drug events.
  • Patients frequently lack awareness of medication administration errors and opportunities for optimization.

Purpose of the Study:

  • To investigate the feasibility and impact of structured approaches to reduce medication regimen complexity in routine care.
  • To evaluate the role of electronic decision support systems in identifying and mitigating factors contributing to medication complexity.
  • To assess whether personalizing complexity reduction strategies enhances patient adherence.

Main Methods:

  • Utilizing electronic decision support tools to systematically identify factors increasing medication regimen complexity.
  • Developing and implementing structured measures to reduce medication complexity.
  • Personalizing the analysis and interventions based on patient preferences.
  • Conducting a prospective trial (HIOPP-6) to gather initial results.

Main Results:

  • Electronic decision support facilitates efficient identification of complexity factors.
  • Appropriate measures can be taken by physicians and pharmacists to reduce medication complexity.
  • Personalization may increase patient readiness for treatment changes and improve adherence.
  • Initial results from the HIOPP-6 trial are anticipated in autumn 2018.

Conclusions:

  • Reducing medication regimen complexity is crucial for improving outpatient care and patient outcomes.
  • Electronic decision support offers a systematic approach to address polypharmacy challenges.
  • Personalized interventions hold promise for enhancing medication adherence and reducing errors.